Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,982
Closed -$579K 1819
2026
Q1
$579K Buy
+1,982
New +$637K ﹤0.01% 1153
2024
Q4
Sell
-2,364
Closed -$799K 1777
2024
Q3
$799K Sell
2,364
-6,343
-73% -$2.03M ﹤0.01% 1040
2024
Q2
$2.56M Buy
+8,707
New +$2.48M 0.02% 692
2024
Q1
Sell
-1,932
Closed -$542K 1731
2023
Q4
$542K Sell
1,932
-1,094
-36% -$274K ﹤0.01% 1012
2023
Q3
$683K Buy
+3,026
New +$655K 0.01% 1121
2021
Q4
Sell
-7,495
Closed -$1.53M 2387
2021
Q3
$1.53M Sell
7,495
-2,364
-24% -$466K 0.02% 841
2021
Q2
$1.74M Buy
9,859
+6,397
+185% +$1.13M 0.02% 751
2021
Q1
$641K Sell
3,462
-625
-15% -$100K 0.01% 1187
2020
Q4
$576K Sell
4,087
-11,761
-74% -$1.5M 0.01% 1164
2020
Q3
$1.74M Buy
+15,848
New +$1.8M 0.03% 452

Other funds holding KAI

Michael Gelband's KAI Position: Q2 2026 in Review

Michael Gelband sold out of Kadant (KAI) in Q2 2026, closing a stake of 1,982 shares — an estimated $579K sold.

Michael Gelband first reported a position in KAI in Q3 2020 and held it in 10 quarters. The position peaked at $2.56M in Q2 2024. 321 funds tracked by Wall St. Rank hold KAI as of Q2 2026.

  • Michael Gelband reported no remaining Kadant position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 1,982 Kadant shares in Q2 2026, an estimated $579K.
  • Michael Gelband first reported a position in Kadant in Q3 2020 and held it in 10 quarters.
  • Michael Gelband's Kadant position peaked at $2.56M in Q2 2024.
  • 321 funds tracked by Wall St. Rank held Kadant as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.